NCT01997840 2025-03-04
ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma
Celgene
Phase 1/2 Terminated
Celgene
Seagen Inc.
National Heart, Lung, and Blood Institute (NHLBI)
M.D. Anderson Cancer Center